We are live on ! Find out more
ICM

Indaba Capital Management Portfolio holdings

AUM $33.8M
1-Year Est. Return 33.83%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+33.83%
3 Year Est. Return
+66.66%
5 Year Est. Return
+44.49%
10 Year Est. Return
+91.89%
AUM
$174M
AUM Growth
-$165M
Cap. Flow
-$170M
Cap. Flow %
-97.59%
Top 10 Hldgs %
100%
Holding
17
New
Increased
1
Reduced
1
Closed
8

Top Buys

Rank Stock Value
1
MACK
Merrimack Pharmaceuticals, Inc.
MACK
+$1.1M

Sector Composition

Rank Sector Weight
1 Technology 35.09%
2 Healthcare 11.17%
3 Financials 0.78%
4 Consumer Discretionary 0%
5 Industrials 0%

Similar funds

Indaba Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Indaba Capital Management held 17 positions worth $174M, down 49% from $339M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Indaba Capital Management withdrew a net $170M in Q4 2023, closing 8 positions and reducing 1 holding. Its most notable exit was Tabula Rasa HealthCare, Inc. Common Stock, an estimated $67.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Indaba Capital Management added an estimated $1.1M to Merrimack Pharmaceuticals, Inc..

  • Indaba Capital Management added most to Merrimack Pharmaceuticals, Inc. in Q4 2023, an estimated $1.1M increase.
  • Indaba Capital Management's biggest Q4 2023 reduction was Blue Owl Capital, cutting an estimated $2.51M.
  • Indaba Capital Management fully exited Tabula Rasa HealthCare, Inc. Common Stock in Q4 2023, selling an estimated $67.2M.
  • Indaba Capital Management's ten largest holdings make up 100% of its $174M portfolio in Q4 2023.
  • Indaba Capital Management opened 0 new positions and closed 8 in Q4 2023.
  • Indaba Capital Management's portfolio value fell 49% quarter-over-quarter to $174M.

Based on Indaba Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.